Recently, we have shown that alterations in EGFR, 7+/10−, and TERTp mutations may have similar prognostic significance in IDH-wildtype GBM as in IDH-wildtype lower-grade tumors in both univariate and multivariate analysis [129] . This evidence concerns the gene IDH2 and glioblastoma.